Vnitr Lek 2018, 64(11):1005-1008 | DOI: 10.36290/vnl.2018.145

Diabetes mellitus in complex older patients

Alena ©mahelová
III. interní gerontometabolická klinika LF UK a FN Hradec Králové

Care of the elderly diabetic patients requires a special approach. What must be considered is not only individualization, and in more fragile elderly patients easing the targets for long-term compensation of diabetes, but also appropriate antidiabetic therapy needs to be chosen. Most patients suffer from polymorbidity and are at a greater risk for occurrence and consequences of hypoglycemia and cognitive impairment. The treatment procedure for sturdy elderly patients with diabetes is not any different from younger patients, while appropriate drugs for fragile patients are gliptins, possibly in combination with a long-term insulin analogue.

Keywords: antidiabetic therapy; complications; diabetes mellitus; level of robustness; old age

Received: September 10, 2018; Accepted: September 14, 2018; Published: November 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©mahelová A. Diabetes mellitus in complex older patients. Vnitr Lek. 2018;64(11):1005-1008. doi: 10.36290/vnl.2018.145.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abdelhafiz AH, Sinclair AJ. Management of Type 2 diabetes in Older People. Diabetes Ther 2013; 4(1): 13-26. Dostupné z DOI: <http://dx.doi.org/10.1007/s13300-013-0020-4>. Go to original source... Go to PubMed...
    2. Nobili A, Garatttini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorbid 2011; 1: 28-44. Go to original source... Go to PubMed...
    3. Tschöpe D, Hanefeld M et al. The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes. Cardiovasc Diabetol 2013; 12:62. Dostupné z DOI: <http://dx.doi.org/10.1186/1475-2840-12-62>. Go to original source... Go to PubMed...
    4. Nair KS. Aging muscle. Am J Clin Nutr 2005; 81(5): 953-963. Dostupné z DOI: <http://dx.doi.org/10.1093/ajcn/81.5.953>. Go to original source... Go to PubMed...
    5. Halter JB, Musi N, Horne FM et al. Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions. Diabetes 2014; 63(8): 2578-2589. Dostupné z DOI: <http://dx.doi.org/10.2337/db14-0020>. Go to original source... Go to PubMed...
    6. Knowler WC, Fowler SE, Hamman RF et al. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374(9702): 1677-1686. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140-6736(09)61457-4>. Erratum in Lancet 2009; 374(9707): 2054. Go to original source... Go to PubMed...
    7. Rejeski WJ, Ip EH, Bertoni AG et al. Look AHEAD Research Group. Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med 2012; 366(13): 1209-1217. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1110294>. Go to original source... Go to PubMed...
    8. De Pablos-Velasco P, Bradley C, de Pablos-Velasco E et al. The PANORAMA pan-European Survey: impact of severe and non-severe hypoglycaemia on quality of life and other patient reported outcomes in patients with type 2 diabetes [Abstract 580]. Diabetologia 2010; 53(Suppl 1): S234-S235.
    9. Inzucchi S, Bergenstal R, Buse J. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38(1): 140-149. Dostupné z DOI: <http://dx.doi.org/10.2337/dc14-2441>. Go to original source... Go to PubMed...
    10. Whitmer RA, Karter AJ, Yaffe KF et al. Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus. JAMA 2009; 301(15): 1565-1572.<http://dx.doi.org/10.1001/jama.2009.460>. Go to original source... Go to PubMed...
    11. Blaum C, Cigolle CT, Boyd C et al. Clinical complexity in middle-aged and older adults with diabetes: the Health and Retirement Study. Med Care 2010; 48(4): 327-334. Go to original source... Go to PubMed...
    12. Svačina ©, Juraąková B, Karen Igor. Diabetes mellitus. Léčba u starąích pacientů v ČR. Doporučené diagnostické a terapeutické postupy pro vąeobecné praktické lékaře. Centrum doporučených postupů pro praktické lékaře. Společnost vąeobecného lékařství, Praha 2014. Dostupné z WWW: <https://docplayer.cz/7799976-Diabetes-mellitus-lecba-u-starsich-pacientu-v-cr-prvni-vydani-2014-doporucene-diagnosticke-a-terapeuticke-postupy-pro-vseobecne-prakticke-lekare.html>.
    13. [American Diabetes Association]. Older Adults: Standards of Medical Care in Diabetes - 2018. Diabetes Care 2018; 41(Suppl 1): S119-S125. Dostupné z DOI: <http://dx.doi.org/10.2337/dc18-S011>. Go to original source... Go to PubMed...
    14. Mostafa SA, Coleman RL, Agbaje OF et al. Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease. Diabet Med 2018; 35(1): 72-77. Dostupné z DOI: <http://dx.doi.org/10.1111/dme.13533>. Go to original source... Go to PubMed...
    15. Scott R, Morgan J, Zimmer Z et al. A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT-R Study. Diabetes Obes Metab 2018; Dostupné z DOI: <http://dx.doi.org/10.1111/dom.13473>. Go to original source... Go to PubMed...
    16. Fioretto P, Stefansson BV, Johnsson E et al. Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment. Diabetologia 2016; 59(9): 2036-2039. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125-016-4017-1>. Go to original source... Go to PubMed...
    17. Roussel R, Duran-Garcia S, Zhang Y et al. Efficacy and Safety of Continuing Sitagliptin When Initiating Insulin Therapy in Subjects With Type 2 Diabetes Mellitus. Poster presented at: ADA 2018; June 22-26, 2018; Orlando, Florida. Diabetes 2018; 67(Supplement 1). Dostupné z DOI: <https://doi.org/10.2337/db18-112-LB>. Go to original source... Go to PubMed...
    18. Halter JB, Musi N, McFarland Horne F. Diabetes and cardiovascular disease in older adults: current status and future directions. Diabetes 2014; 63(8):2578-2589. Dostupné z DOI: <http://doi:10.2337/db14-0020>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.